11/2/2026
Filament Health completes ibogaine extraction, begins testing
Rhelion Life Sciences advances ibogaine drug development with new extraction and stability testing.
Topic archive
toronto
5 stories
10/5/2026
AdvisorShares Trust holds 6.78% stake in Psyence Biomedical
The investment firm reports significant ownership in Psyence Biomedical as of September 2026.
9/28/2026
Psyence Biomedical secures $1.3M ibogaine licensing deal
Texas subsidiary gains exclusive U.S. rights to PsyLabs' ibogaine
9/23/2026
NeuroThera expands U.S. patent portfolio with Clearmind
New patent applications cover LSD, ketamine, and ibogaine combinations for mental health.
9/10/2026
Filament Health plans stability program for ibogaine drug
IBEX011 stability program aims to meet growing demand for standardized ibogaine.